ZYUS Life Sciences Corporation
ZLSCF
$0.01
-$0.03-65.75%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 84.70K | 259.20K | 409.90K | 409.90K | 461.30K |
| Total Receivables | 244.90K | 281.40K | 248.60K | 248.60K | 218.50K |
| Inventory | 176.70K | 328.80K | 396.70K | 396.70K | 398.70K |
| Prepaid Expenses | 148.70K | 277.10K | 265.40K | 265.40K | 242.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 655.00K | 1.15M | 1.32M | 1.32M | 1.32M |
|
|
|||||
| Total Current Assets | 655.00K | 1.15M | 1.32M | 1.32M | 1.32M |
| Net Property, Plant & Equipment | 2.60M | 6.55M | 7.22M | 7.22M | 7.26M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 97.00K | 96.90K | 99.00K | 99.00K | 105.80K |
| Total Assets | 3.36M | 7.79M | 8.64M | 8.64M | 8.69M |
|
|
|||||
| Total Accounts Payable | 4.80M | 6.22M | 6.28M | 6.28M | 5.25M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 815.90K | 1.32M | 136.40K | 136.40K | 58.40K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.17M | 3.72M | 3.62M | 3.62M | 3.29M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.78M | 11.26M | 10.03M | 10.03M | 8.60M |
|
|
|||||
| Total Current Liabilities | 11.78M | 11.26M | 10.03M | 10.03M | 8.60M |
| Long-Term Debt | 7.54M | 4.37M | 4.21M | 4.21M | 3.79M |
| Short-term Debt | 815.90K | 1.32M | 136.40K | 136.40K | 58.40K |
| Capital Leases | 1.24M | 1.47M | 1.57M | 1.57M | 1.49M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 20.56M | 17.10M | 15.81M | 15.81M | 13.88M |
|
|
|||||
| Common Stock & APIC | 121.42M | 121.77M | 123.89M | 123.89M | 115.99M |
| Retained Earnings | -142.77M | -133.53M | -133.72M | -133.72M | -123.80M |
| Treasury Stock & Other | 4.15M | 2.45M | 2.66M | 2.66M | 2.62M |
| Total Common Equity | -17.20M | -9.31M | -7.17M | -7.17M | -5.20M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.20M | -9.31M | -7.17M | -7.17M | -5.20M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.20M | -9.31M | -7.17M | -7.17M | -5.20M |
|
|
|||||